On Friday, March 27, join two experts from Johns Hopkins Center for Health Security who will be answering your questions about what is known about the virus, how the health system is responding, how the outbreak might end and strategies for journalists to combat misinformation.
Michele Cohen Marill is one of three journalists glad to be back in the U.S.
Marill, an Atlanta-based independent journalist, is one of four 2020 AHCJ International Health Study fellows and was in Germany conducting interviews for her fellowship when President Trump announced the unprecedented travel restrictions from Europe to the U.S. on March 11. Continue reading
An inaccurate statement that President Trump made during a March 19 news briefing — that the malaria drug hydroxychloroquine had been approved as a COVID-19 treatment — demonstrates how skeptical journalists should remain when covering the unfolding story about treatments and preventative measures.
While there are more than 85 trials for vaccines and treatments underway for COVID-19, scientists don’t expect them to be available to the public soon, despite what some headlines suggest. Continue reading
Journalists racing to cover the unfolding COVID-19 outbreak in the U.S. should carefully vet sources they are quoting to minimize misinformation, two infectious disease experts a journalist told AHCJ members this week.
It’s particularly easy for broadcast and social media to inadvertently amplify the voices of people who may not be experts on COVID-19. That makes it harder for the public to decide how best to protect themselves and their families from contracting COVID-19, the disease caused by the coronavirus SARS-CoV-19. Continue reading
With the number of COVID-19 cases expanding exponentially, the story about the potential for treatments and vaccines remains a top priority. So does the story of drug pricing.
At a March 5 media briefing on Capitol Hill, biopharmaceutical company executives updated legislaters on potential medical countermeasures for stopping the SARS-CoV-2 virus, which causes the disease COVID-19.
As the opioid crisis has continued to plague the nation, a less-reported story for journalists to consider is the surging number of bacterial and viral infections threatening to make the crisis worse.
The rise includes an increase in bacterial infections caused by Staphlococcus aureus, a pathogen that is often resistant to antibiotics – and a climb in new HIV, hepatitis, sexually transmitted diseases and skin and soft tissue infections.